Ivermectin doesn’t cut Covid-19 hospitalization risk, new study shows

By Marthe Fourcade | Bloomberg

A large study on the anti-parasitic drug ivermectin, which has gained popularity as an alternative therapy for Covid-19, found that the medicine didn’t help keep patients out of the hospital.

Scientists in Brazil who followed more than 1,300 patients assigned to take either the drug or a placebo for three days also found that ivermectin treatment didn’t help with a number of other health measures such as viral clearance after a week, speed of recovery or risk of death. The study results were published in the New England Journal of Medicine.

The study, thanks to its breadth and detail, should help settle the debate on ivermectin’s role as a Covid treatment. The drug gained traction early in the pandemic, when doctors were looking to repurpose older medicines to help save patients. Smaller trials offered conflicting results. Even after the World Health Organization said last year there was only very low certainty evidence that ivermectin worked for Covid and advised against its use, some doctors continued prescribing the drug.

Source link

Leave a Reply

Your email address will not be published.